» Articles » PMID: 16773379

Senescence in Human Intervertebral Discs

Overview
Journal Eur Spine J
Specialty Orthopedics
Date 2006 Jun 15
PMID 16773379
Citations 140
Authors
Affiliations
Soon will be listed here.
Abstract

Intervertebral discs demonstrate degenerative changes relatively early in life. Disc degeneration, in turn, is associated with back pain and disc herniation, both of which cause considerable clinical problems in the western world. Cell senescence has been linked to degenerative diseases of other connective tissues such as osteoarthritis. Thus we investigated the degree of cell senescence in different regions of discs from patients with different disc disorders. Discs were obtained from 25 patients with disc herniations; from 27 patients undergoing anterior surgery for either back pain due to degenerative disc disease (n = 25) or spondylolisthesis (n = 2) and from six patients with scoliosis. In addition, four discs were obtained post-mortem. Samples were classified as annulus fibrosus or nucleus pulposus and tissue sections were assessed for the degree of cell senescence (using the marker senescence-associated-beta-galactosidase (SA-beta-Gal)) and the number of cells present in clusters. There were significantly more SA-beta-Gal positive cells in herniated discs (8.5% of cells) than those with degenerative disc disease, spondylolisthesis, scoliosis, or cadaveric discs (0.5% of cells; P < 0.001). There was more senescence of cells of the nucleus pulposus compared to those of the annulus fibrosus and in herniated discs a higher proportion of cells in cell clusters (defined as groups of three or more cells) were SA-beta-Gal positive (25.5%) compared to cells not in clusters (4.2%, P < 0.0001). This study demonstrates an increased degree of cell senescence in herniated discs, particularly in the nucleus where cell clusters occur. These clusters have been shown previously to form via cell proliferation, which is likely to explain the increased senescence. These findings could have two important clinical implications: firstly, that since senescent cells are known to behave abnormally in other locations, they may lead to deleterious effects on the disc matrix and so contribute to the pathogenesis and secondly, cells from such tissue may not be ideal for cell therapy and repair via tissue engineering.

Citing Articles

Reprogramming to restore youthful epigenetics of senescent nucleus pulposus cells for mitigating intervertebral disc degeneration and alleviating low back pain.

Ma W, Wang W, Zhao L, Fan J, Liu L, Huang L Bone Res. 2025; 13(1):35.

PMID: 40075068 PMC: 11903667. DOI: 10.1038/s41413-025-00416-1.


Exploring and analyzing two aging related genes FPR1 and UCHL1 and their potential molecular mechanisms in aggravating lumbar disc herniation.

Zhao D, Sha B, Zeng L, Liang G, Huang H, Pan J J Orthop Surg Res. 2024; 19(1):841.

PMID: 39695855 PMC: 11657882. DOI: 10.1186/s13018-024-05257-y.


Gene-Silencing Therapeutic Approaches Targeting PI3K/Akt/mTOR Signaling in Degenerative Intervertebral Disk Cells: An In Vitro Comparative Study Between RNA Interference and CRISPR-Cas9.

Ryu M, Yurube T, Takeoka Y, Kanda Y, Tsujimoto T, Miyazaki K Cells. 2024; 13(23).

PMID: 39682777 PMC: 11640589. DOI: 10.3390/cells13232030.


Exploration and breakthrough in the mode of intervertebral disc cell death may lead to significant advances in treatments for intervertebral disc degeneration.

Chen H, Tang T, Xue C, Liu X, Xi Z, Xie L J Orthop Surg Res. 2024; 19(1):825.

PMID: 39639370 PMC: 11619685. DOI: 10.1186/s13018-024-05280-z.


An anti-senescence hydrogel with pH-responsive drug release for mitigating intervertebral disc degeneration and low back pain.

Wang W, Liu L, Ma W, Zhao L, Huang L, Zhou D Bioact Mater. 2024; 41:355-370.

PMID: 39171275 PMC: 11338064. DOI: 10.1016/j.bioactmat.2024.07.031.


References
1.
Alini M, Roughley P, Antoniou J, Stoll T, Aebi M . A biological approach to treating disc degeneration: not for today, but maybe for tomorrow. Eur Spine J. 2002; 11 Suppl 2:S215-20. PMC: 3611567. DOI: 10.1007/s00586-002-0485-8. View

2.
Ganey T, Meisel H . A potential role for cell-based therapeutics in the treatment of intervertebral disc herniation. Eur Spine J. 2002; 11 Suppl 2:S206-14. PMC: 3611582. DOI: 10.1007/s00586-002-0494-7. View

3.
Martin J, Buckwalter J . The role of chondrocyte senescence in the pathogenesis of osteoarthritis and in limiting cartilage repair. J Bone Joint Surg Am. 2003; 85-A Suppl 2:106-10. DOI: 10.2106/00004623-200300002-00014. View

4.
Price J, Waters J, Darrah C, Pennington C, Edwards D, Donell S . The role of chondrocyte senescence in osteoarthritis. Aging Cell. 2003; 1(1):57-65. DOI: 10.1046/j.1474-9728.2002.00008.x. View

5.
Martin J, Brown T, Heiner A, Buckwalter J . Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Relat Res. 2004; (427 Suppl):S96-103. DOI: 10.1097/01.blo.0000143818.74887.b1. View